Business and industry

Easy Access IP

Browse our Easy Access IP deals, available to companies and individuals to licence FREE.

Commercial Deals

Browse our Commercial Deals to find technologies available for licensing and co-development.


 

Easy Access Licence Terms

Find out more:

One of the core missions of the University is the creation, advancement and sharing of knowledge and we aim to transfer as much IP into commercial use as we can, to the benefit of our partners, the community and the economy.

As well as our range of Commercial Deals, we have launched a range of Intellectual Property that is available free of charge to businesses and individuals who think they can exploit the technology and are interested in working with the University.

Easy Access IP offers cutting edge innovation and patents to those who can make best use of the research.

University of Glasgow is a co-founding partner of Easy Access Innovation, together with King’s College London and the University of Bristol. To find out which technologies are being offered as Easy Access IP by our partners follow the links below:

 King’s College London’s opportunities

University of Bristol’s opportunities

 Easy Access Innovation is open to other UK and international universities to join. Read more about the initiative and how you can join.

Technology Commercialisation Case Studies 

  • The Glasgow Program – World Leading Software for ECG Analysis

    The University’s automated Electrocardiogram (ECG) Interpretation Algorithm is considered one of the top three resting ECG automated interpretive algorithms in the world. The software has been adopted commercially, and is used globally by some of the world’s leading electro-medical device manufacturers.

  • SPEED - Scottish Power Electronics and Electric Drives

    For over 20 years the SPEED lab has worked with major manufacturers in electrical engineering industry across the world. It is one of the University’s most successful examples of industrial collaboration.

  • Target Controlled Infusion (TCI) for Anaesthesia

    Collaboration between Glasgow researchers and AstraZeneca Pharmaceuticals, led to the development of the first commercially available Target Controlled Infusion system (Diprifusor) for propofol, an anaesthetic. More than 10,000 Diprifusors have since been introduced to over 25 countries throughout the world.